Resilience raises over $800 million to transform pharmaceutical manufacturing in response to COVID-19
TechCrunch
NOVEMBER 23, 2020
According to a statement, the company will invest heavily in developing new manufacturing technologies across cell and gene therapies, viral vectors, vaccines and proteins. billion to spend on sustainability and health-focused biotech. “It Founded by ARCH Venture Partners investor Robert Nelsen, National Resilience Inc.,
Let's personalize your content